Cetuximab
Links shared publicly online about this topic
Oncology Article | cetuximab
mdlinx.com — “Dual kinase inhibition of EGFR and HER2 overcomes resistance to cetuximab in a novel in vivo model of acquired cetuximab resistance” View full resource at mdlinx.com
Most Recently Shared on July 29, 2011 at 2:28 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dual kinase inhibition of EGFR and HER2 overcomes resistance to cetuximab in a novel in vivo model of ... http://bit.ly/qBz8PI #oncology
Cetuximab Helps Treat Colorectal Cancer:
health.msn.com — “Cetuximab Helps Treat Colorectal Cancer:” View full resource at health.msn.com
Most Recently Shared on November 25, 2009 at 5:46 pm By:
Cetuximab Helps Treat Colorectal Cancer: http://bit.ly/8Adnhc
ingentaconnect Cetuximab: Psoriasis: case report
ingentaconnect.com — “ingentaconnect Cetuximab: Psoriasis: case report” View full resource at ingentaconnect.com
Most Recently Shared on April 13, 2011 at 12:06 am By:
Cetuximab: Psoriasis: case report: (Source: Reactions)MedWorm Sponsor Message: Find out how you can get your mes... http://bit.ly/fOUk37
ingentaconnect Cetuximab: Interstitial pneumonia: case report
ingentaconnect.com — “ingentaconnect Cetuximab: Interstitial pneumonia: case report” View full resource at ingentaconnect.com
Most Recently Shared on February 6, 2011 at 9:54 pm By:
Cetuximab: Interstitial pneumonia: case report: (Source: Reactions)MedWorm Sponsor Message: Watch the new MedWor... http://bit.ly/eeJDSj
Dr. Vokes on Cetuximab for Head and Neck Cancer
onclive.com — “Dr. Everett Vokes from University of Chicago Medical Center on Cetuximab for Head and Neck Cancer” View full resource at onclive.com
Most Recently Shared on December 6, 2011 at 9:22 pm By:
Dr. Everett Vokes from @UChicago on Cetuximab for Head and Neck Cancer http://t.co/Yh8m7uPd #onclivetv
Roxon vows to tackle cetuximab delay | Gastroenterology Update
gastroenterologyupdate.com.au — “Federal Health Minister Nicola Roxon has appeared on talkback radio this morning promising to “push very hard” to overcome delays in PBS listing the bowel cancer drug, cetuximab, amid mounting public frustration.” View full resource at gastroenterologyupdate.com.au
Most Recently Shared on June 15, 2011 at 4:24 am By:
Gastroenterology Upd Gastroenterology and Medical Publisher
Roxon vows to tackle cetuximab delay http://bit.ly/kVUFJZ #gastroenterology
Dr. West on NSCLC Afatinib and Cetuximab Combination
onclive.com — “Dr. H. Jack West from Swedish Cancer Institute discusses Afatinib and Cetuximab Combination in NSCLC” View full resource at onclive.com
Most Recently Shared on July 7, 2011 at 9:30 pm By:
@JackWestMD from @Swedish Discusses Afatinib and Cetuximab Combination in NSCLC http://t.co/uCxC6d4
Cetuximab Combination Fails to Deliver Benefit in HNSCC
onclive.com — “Patients with locally advanced head and neck cancer gained no survival benefit with the addition of cetuximab to chemoradiation.” View full resource at onclive.com
Most Recently Shared on August 30, 2011 at 2:09 pm By:
Cetuximab Combination Fails to Deliver Benefit in advanced or metastatic head and neck squamous cell carcinoma http://t.co/zC0uhP9
Cost-effectiveness of cetuximab in metastatic colorectal cancer
physorg.com — “From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a study published online August 7 in the Journal of the National Cancer Institute.” View full resource at physorg.com
Most Recently Shared on August 8, 2009 at 10:10 am By:
Cost-effectiveness of cetuximab in metastatic colorectal cancer http://bit.ly/14eL6k
Cetuximab goes on PBS | Gastroenterology Update
gastroenterologyupdate.com.au — “The impasse over the PBS listing of new drugs has broken, with the Federal Government yesterday announcing $200 million worth of new subsidised medicines, including erbitux – almost a year after it was recommended by the PBAC.” View full resource at gastroenterologyupdate.com.au
Most Recently Shared on June 22, 2011 at 3:23 am By:
Gastroenterology Upd Gastroenterology and Medical Publisher
Cetuximab goes on PBS http://bit.ly/l5IgIs #gastroenterology
Improved Outcomes For HPV-Positive Head And Neck Cancer With Cetuximab And IMRT
medicalnewstoday.com — “Studies have shown higher survival rates for people with head and neck cancers that test positive for HPV when they are treated with systemic chemotherapy and radiation therapy. Now a new study s” View full resource at medicalnewstoday.com
Most Recently Shared on October 27, 2010 at 10:58 am By:
Ear, Nose, and Throat OW Health
Improved Outcomes For HPV-Positive Head And Neck Cancer With Cetuximab And IMRT: Studies have shown higher surviva... http://mnt.to/f/3LKv
Erbitux (Cetuximab) Approved For Metastatic Head And Neck Cancer, USA
medicalnewstoday.com — “Erbitux (cetuximab) has been approved by the US FDA for combination use with chemotherapy for late-stage head and neck cancer treatment. When given together with chemotherapy, Erbitus was found to” View full resource at medicalnewstoday.com
Most Recently Shared on November 8, 2011 at 7:05 am By:
MNT Drug Approvals Health News
Erbitux (cetuximab) Approved For Metastatic Head And Neck Cancer, USA http://t.co/zZZhKwbc #regulatory
IngentaConnect Cetuximab for Recurrent andor Metastatic Squamous Cell Carcinoma ...
ingentaconnect.com — “IngentaConnect Cetuximab for Recurrent andor Metastatic Squamous Cell Carcinoma ...” View full resource at ingentaconnect.com
Most Recently Shared on May 15, 2010 at 6:07 pm By:
Cetuximab for Recurrent andor Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Ap... http://bit.ly/aOyHed
FDA Approves Cetuximab for Metastatic Head and Neck Cancer | Oral Cancer News
oralcancernews.org — “FDA Approves Cetuximab for Metastatic Head and Neck Cancer | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on November 8, 2011 at 2:00 pm By:
New recommendations advise against use of cetuximab in colon cancer therapy - ONA
oncologynurseadvisor.com — “Researchers have issued a recommendation for the use of cetuximab in colon cancer therapy, according to a report published in the July 2010 issue of the American Society for Clinical Oncology Post.” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 4, 2010 at 3:07 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
New recommendations advise against use of cetuximab in colon cancer therapy http://goo.gl/fb/CPDBL
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
msn
-
Psoriasis OW
Organizing psoriasis resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
